By Dave Ross, ScD, President and Chief Executive Officer for The Task Force for Global Health Most people in the world do not have access
“Data is power.” That was the message that The Task Force and its trachoma elimination partners brought to technology leaders during a March 11 panel
Key stakeholders in the global fight to eliminate intestinal worms as a public health problem will now emphasize measuring disease levels to track program impact.
By Genevieve LaCon, MPH, senior program associate, International Trachoma Initiative, The Task Force for Global Health Six months into my position at The Task Force’s
Maria Rebollo Polo, MD, MPH, former director of programs for The Task Force’s Neglected Tropical Diseases (NTD) Support Center, has been named team leader for
A new smartphone-based data platform called Tropical Data is helping 13 countries in Africa, Asia, and Latin America track their progress towards the elimination of
A new web-based tool developed by The Task Force and partners has significantly reduced turnover of healthcare workers in Mozambique and brought greater stability to
GSK Chief Executive Officer (CEO) Sir Andrew Witty is one of the pharmaceutical industry’s most passionate advocates for increasing access to essential medicines and vaccines
The Task Force is facilitating clinical trials for a promising new treatment to combat a disfiguring disease known as elephantiasis, which can result from infection
The Task Force is supporting the development of two new polio antiviral therapies to treat immune-deficient people who excrete poliovirus after receiving oral polio vaccine
As evidence mounts that the current Zika epidemic in Latin America may have peaked, the public health effort is now shifting to developing a long-term
The Task Force for Global Health is ranked second in Forbes‘ 2016 list of the 50 largest U.S. charities, up from fourth place in 2015. Each
Header photo caption: A drug distributor travels long distances to a remote village in Cameroon to get medicines for onchocerciasis (river blindness) and lymphatic filariasis to marginalized societies most in need.